Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  European journal of pharmaceutics and biopharmaceutics

• Publication date

  2011-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejpb.2010.11.015PMID 21118722
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Design of fluorescently tagged poly(alkyl cyanoacrylate) nanoparticles for human brain endothelial cell imaging.

  2010cited by this paper
• Two-step synthesis of multivalent cancer-targeting constructs.

  2010cited by this paper
• Liposomes and Drug Delivery

  2010cited by this paper
• Targeting Anticancer Drugs to Tumor Vasculature Using Cationic Liposomes

  2010cited by this paper
• Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals.

  2010cited by this paper
• Identification of Peptide Ligands for Targeting to the Blood-Brain Barrier

  2010cited by this paper
• Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones.

  2009cited by this paper
• Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB).

  2009cited by this paper
• Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier.

  2009cited by this paper
• The human brain endothelial cell line hCMEC/D3 as a human blood‐brain barrier model for drug transport studies

  2008cited by this paper
• The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?

  2008cited by this paper
• Pharmaceutical manufacturing handbook : production and processes

  2008cited by this paper
• Integrity of liposomes in presence of various formulation excipients, when dispersed in aqueous media and in hydrogels.

  2008cited by this paper
• Solid Lipid Nanoparticles Enhance the Delivery of the HIV Protease Inhibitor, Atazanavir, by a Human Brain Endothelial Cell Line

  2008cited by this paper
• Development of a Smart Nano-vehicle to Target Cerebrovascular Amyloid Deposits and Brain Parenchymal Plaques Observed in Alzheimer’s Disease and Cerebral Amyloid Angiopathy

  2008cited by this paper
• Drug Targeting to the Brain

  2007cited by this paper
• Translocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis.

  2007cited by this paper
• Blood-brain barrier delivery.

  2007cited by this paper
• Single-drug multiligand conjugates: synthesis and preliminary cytotoxicity evaluation of a paclitaxel-dipeptide "scorpion" molecule.

  2006cited by this paper
• Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release.

  2005cited by this paper
• Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line

  2005cited by this paper
• Nanogels for oligonucleotide delivery to the brain.

  2004cited by this paper
• Targeting of skeletal muscle in vitro using biotinylated immunoliposomes.

  2004cited by this paper
• Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain.

  2004cited by this paper
• Antibody targeted gene transfer to endothelium

  2003cited by this paper
• Modulation of transendothelial permeability and expression of ATP-binding cassette transporters in cultured brain capillary endothelial cells by astrocytic factors and cell-culture conditions

  2003cited by this paper
• Evaluation of the immortalised mouse brain capillary endothelial cell line, b.End3, as an in vitro blood-brain barrier model for drug uptake and transport studies.

  2003cited by this paper
• Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier

  2002cited by this paper
• Antisense gene therapy of brain cancer with an artificial virus gene delivery system.

  2002cited by this paper
• Nanoparticulate systems for brain delivery of drugs.

  2001cited by this paper
• Endocytosis and Transcytosis of an Immunoliposome-Based Brain Drug Delivery System

  2000cited by this paper
• Stability of SUV liposomes in the presence of cholate salts and pancreatic lipases: effect of lipid composition.

  2000cited by this paper
• Dexamethasone Regulation of P‐Glycoprotein Activity in an Immortalized Rat Brain Endothelial Cell Line, GPNT

  1999cited by this paper
• Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.

  1997cited by this paper
• Evidence for P‐glycoprotein‐modulated penetration of morphine‐6‐glucuronide into brain capillary endothelium

  1996cited by this paper
• Brain drug delivery of small molecules using immunoliposomes.

  1996cited by this paper
• Regulation of gamma‐glutamyl transpeptidase and alkaline phosphatase activities in immortalized rat brain microvessel endothelial cells

  1994cited by this paper
• A cell culture model of the blood-brain barrier

  1991cited by this paper
• Endocytosis and intracellular fate of liposomes using pyranine as a probe.

  1990cited by this paper
• Endocytosis of liposomes by macrophages: binding, acidification and leakage of liposomes monitored by a new fluorescence assay.

  1990cited by this paper
• A non-covalent method of attaching antibodies to liposomes.

  1987cited by this paper
• Synthesis of nucleosomal histone variants during wheat grain development.

  1987cited by this paper
• Colorimetric determination of phospholipids with ammonium ferrothiocyanate.

  1980cited by this paper

• Assessment of intranasal permeability and pharmacological activity of glyburide-loaded nanosuspension formulation for Alzheimer's disease.

  2025cites this paper
• Engineered PAM-SPION Nanoclusters for Enhanced Cancer Therapy: Integrating Magnetic Targeting with pH-Responsive Drug Release

  2025cites this paper
• Nano-Encapsulated Taro Lectin Can Cross an in vitro Blood-Brain Barrier, Induce Apoptosis and Autophagy and Inhibit the Migration of Human U-87 MG Glioblastoma Cells

  2025cites this paper
• Thiazole Derivatives as Promising Candidates for Cryptococcosis Therapy

  2025cites this paper
• Iron Reduces the Trafficking of Fatty Acids from Human Immortalised Brain Microvascular Endothelial Cells Through Modulation of Fatty Acid Transport Protein 1 (FATP1/SLC27A1)

  2024cites this paper
• A guide for blood–brain barrier models

  2024cites this paper
• Wnt-Regulated Therapeutics for Blood-Brain Barrier Modulation and Cancer Therapy.

  2024cites this paper
• Cell type-targeting nanoparticles in treating central nervous system diseases: Challenges and hopes

  2023cites this paper
• Parenteral Lipid-Based Nanoparticles for CNS Disorders: Integrating Various Facets of Preclinical Evaluation towards More Effective Clinical Translation

  2023cites this paper
• Trafficking through the blood–brain barrier is directed by core and outer surface components of layer‐by‐layer nanoparticles

  2023cites this paper
• Enhancement of Microglia Functions by Developed Nano‐Immuno‐Synergist to Ameliorate Immunodeficiency for Malignant Glioma Treatment

  2023cites this paper
• Comparative Studies of the Uptake and Internalization Pathways of Different Lipid Nano-Systems Intended for Brain Delivery

  2023cites this paper
• Recent Advancements in Nanocarrier-assisted Brain Delivery of Phytochemicals Against Neurological Diseases

  2023cites this paper
• Assessment of zonula occluden-1 expression by Wnt/β-catenin pathway activators in hCMEC/D3 cells

  2022cites this paper
• Polystyrene nanoplastics penetrate across the blood-brain barrier and induce activation of microglia in the brain of mice.

  2022cites this paper
• Nanotechnology-based drug delivery for the treatment of CNS disorders

  2022cites this paper
• Core material and surface chemistry of Layer-by-Layer (LbL) nanoparticles independently direct uptake, transport, and trafficking in preclinical blood-brain barrier (BBB) models

  2022cites this paper
• Combinatorial therapeutic strategies for enhanced delivery of therapeutics to brain cancer cells through nanocarriers: current trends and future perspectives

  2022cites this paper
• A Historical Review of Brain Drug Delivery

  2022cites this paper
• Critical Review of Lipid-Based Nanoparticles as Carriers of Neuroprotective Drugs and Extracts

  2021cites this paper
• Recent Advances in the Use of Lipid-Based Nanoparticles Against Glioblastoma Multiforme

  2021cites this paper
• Targeting Energy Metabolism to Overcome Therapeutic Resistance of Glioblastoma and Tumor-associated Edema

  2021cites this paper
• Recent advances in the design of inorganic and nano-clay particles for the treatment of brain disorders.

  2021cites this paper
• Surface Functionalization of PLGA Nanoparticles to Increase Transport across the BBB for Alzheimer’s Disease

  2021cites this paper
• In vitro and In vivo Optimization of Liposomal Nanoparticles Based Brain Targeted Vgf Gene Therapy.

  2021cites this paper
• Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs

  2020cites this paper
• Muscone/RI7217 co-modified upward messenger DTX liposomes enhanced permeability of blood-brain barrier and targeting glioma

  2020cites this paper
• Drug Delivery System Targeting CD4+ T Cells for HIV-1 Latency Reactivation Towards the Viral Eradication.

  2020cites this paper
• In vitro and in vivo evaluation of a single chain antibody fragment generated in planta with potent rabies neutralisation activity

  2019cites this paper
• Cellular Vesicles: New Insights in Engineering Methods, Interaction with Cells and Potential for Brain Targeting

  2019cites this paper
• Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy.

  2019cites this paper
• The endo-lysosomal system of bEnd.3 and hCMEC/D3 brain endothelial cells

  2019cites this paper
• Carrier-mediated transportation through BBB

  2019cites this paper
• In vitro and in vivo models of BBB to evaluate brain targeting drug delivery

  2019cites this paper
• Neutrophil-Derived Microvesicle Induced Dysfunction of Brain Microvascular Endothelial Cells In Vitro

  2019cites this paper
• Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.

  2019cites this paper
• Stealth and Cationic Nanoliposomes as Drug Delivery Systems to Increase Andrographolide BBB Permeability

  2018cites this paper
• Phyto-Therapeutic and Nanomedicinal Approaches to Cure Alzheimer’s Disease: Present Status and Future Opportunities

  2018cites this paper
• A Screening Strategy for Evaluation of Drug Transport across the Blood-Brain Barrier: Application to Catechol-O-methyltransferase Inhibitors, Dopamine β-hydroxylase Inhibitors and Dibenz[b,f]azepine-5-carboxamide Derivatives

  2018cites this paper
• Multifunctional doxorubicin‐loaded magnetoliposomes with active and magnetic targeting properties

  2018cites this paper
• Specific delivery of idarubicin to HER2-positive breast cancerous cell line by trastuzumab-conjugated liposomes

  2018cites this paper
• Gold Nanoparticles as a Delivery System of Oligonucleotides into the Brain

  2017cites this paper
• Liposomes containing cyclodextrins or meglumine to solubilize and improve the bioavailability of poorly soluble drugs

  2017cites this paper
• Multifunctional LUV liposomes decorated for BBB and amyloid targeting. A. In vitro proof‐of‐concept

  2017cites this paper
• Targeting transferrin receptors at the blood-brain barrier improves the uptake of immunoliposomes and subsequent cargo transport into the brain parenchyma

  2017cites this paper
• Curcumin in Alzheimer's disease: Can we think to new strategies and perspectives for this molecule?

  2017cites this paper
• Multifunctional LUV liposomes decorated for BBB and amyloid targeting ‐ B. In vivo brain targeting potential in wild‐type and APP/PS1 mice

  2017cites this paper
• Enhanced transport of plant‐produced rabies single‐chain antibody‐RVG peptide fusion protein across an in cellulo blood–brain barrier device

  2017cites this paper
• Resveratrol and Grape Extract-loaded Solid Lipid Nanoparticles for the Treatment of Alzheimer’s Disease

  2017influential citation
• Evaluation of brain-targeted chitosan nanoparticles through blood–brain barrier cerebral microvessel endothelial cells

  2017cites this paper
• Targeted Nanoparticles for the Treatment of Alzheimer's Disease.

  2017cites this paper
• Nano carriers for drug transport across the blood–brain barrier

  2017cites this paper
• Recent advancements in liposomes targeting strategies to cross blood‐brain barrier (BBB) for the treatment of Alzheimer's disease

  2017cites this paper
• Evaluation of the adaptogenic potential exerted by ginsenosides Rb1 and Rg1 against oxidative stress-mediated neurotoxicity in an in vitro neuronal model

  2017cites this paper
• In Vitro CNS Models

  2017cites this paper
• Synthesis and Characterization of Polymeric Nanoparticles for Delivery Through the Blood Brain Barrier of Drugs Against the Human African Trypanosomiasis.

  2016cites this paper
• Glutathione conjugation dose-dependently increases brain-specific liposomal drug delivery in vitro and in vivo.

  2016cites this paper
• Butylglyceryl-modified polysaccharide nanoparticles for drug delivery to the brain

  2016cites this paper
• How do the physicochemical properties of nanoliposomes affect their interactions with the hCMEC/D3 cellular model of the BBB?

  2016cites this paper
• Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer's disease treatment.

  2016cites this paper
• In vitro screening of nanomedicines through the blood brain barrier: A critical review.

  2016cites this paper
• Revisiting nanoparticle technology for blood-brain barrier transport: Unfolding at the endothelial gate improves the fate of transferrin receptor-targeted liposomes.

  2016cites this paper
• Limitations of the hCMEC/D3 cell line as a model for Aβ clearance by the human blood‐brain barrier

  2016cites this paper
• Potential Nanocarriers for Brain Drug Delivery

  2016cites this paper
• Role of Nanotechnology for Enzyme Replacement Therapy in Lysosomal Diseases. A Focus on Gaucher's Disease.

  2016cites this paper
• Synthesis and properties of a series of carboranyl-BODIPYs.

  2015cites this paper
• Stealth anti-CD4 conjugated immunoliposomes with dual antiretroviral drugs--modern Trojan horses to combat HIV.

  2015cites this paper
• New [18F]Tracers for Alzheimer's Disease Imaging. Labeling Synthesis And Biological Testing

  2015cites this paper
• The interaction of carbon nanotubes with an in vitro blood-brain barrier model and mouse brain in vivo

  2015cites this paper
• A D-peptide ligand of nicotine acetylcholine receptors for brain-targeted drug delivery.

  2015cites this paper
• Nanoparticles for Brain Drug Delivery

  2015cites this paper
• Immunoliposomes doubly targeted to transferrin receptor and to α-synuclein

  2015cites this paper
• Comparison of Various Types of Ligand Decorated Nanoliposomes for their Ability to Inhibit Amyloid Aggregation and to Reverse Amyloid Cytotoxicity.

  2015cites this paper
• Nanoparticles and the Blood-Brain Barrier: Advancing from In-Vitro Models Towards Therapeutic Significance

  2015cites this paper
• Cardiolipin-incorporated liposomes with surface CRM197 for enhancing neuronal survival against neurotoxicity.

  2014cites this paper
• Nanoparticle-based drug delivery to improve the efficacy of antiretroviral therapy in the central nervous system

  2014cites this paper
• Nanoparticle formulation improves the anticonvulsant effect of clonazepam on the pentylenetetrazole-induced seizures: behavior and electroencephalogram.

  2014cites this paper
• Nanotechnology and Alzheimer's disease: what has been done and what to do.

  2014cites this paper
• Transport of Glial Cell Line-Derived Neurotrophic Factor into Liposomes across the Blood-Brain Barrier: In Vitro and in Vivo Studies

  2014cites this paper
• Synthesis and in Vitro Evaluation of BBB Permeability, Tumor Cell Uptake, and Cytotoxicity of a Series of Carboranylporphyrin Conjugates

  2014cites this paper
• Mono and Dually Decorated Nanoliposomes for Brain Targeting, In Vitro and In Vivo Studies

  2014cites this paper
• A Human Blood-Brain Barrier Transcytosis Assay Reveals Antibody Transcytosis Influenced by pH-Dependent Receptor Binding

  2014cites this paper
• Advances in investigations on the mechanism of cancer multidrug resistance and the liposomes-based treatment strategy

  2014cites this paper
• Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?

  2014cites this paper
• Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: implications for therapy of Alzheimer disease.

  2014cites this paper
• Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: a review.

  2014cites this paper
• Colloidal supramolecular aggregates for therapeutic application in neuromedicine.

  2014cites this paper
• Multifunctional nanoliposomes with curcumin-lipid derivative and brain targeting functionality with potential applications for Alzheimer disease.

  2014cites this paper
• Liposomes: versatile and biocompatible nanovesicles for efficient biomolecules delivery.

  2014cites this paper
• Neuroprotection against degeneration of sk-N-mc cells using neuron growth factor-encapsulated liposomes with surface cereport and transferrin.

  2014cites this paper
• Targeting nanoparticles across the blood-brain barrier with monoclonal antibodies.

  2014cites this paper
• Potential of nanoliposomes for the therapy and/or diagnosis of Alzheimer’s disease: recent progress

  2014cites this paper
• Dual Modified Liposomes for Drug and Gene Delivery to Brain

  2014cites this paper
• EFFECT OF THE CELL POLARIZATION ON ENDOCYTIC PROPERTIES OF THE HUMAN BRAIN ENDOTHELIAL CELLS

  2014cites this paper
• Retro-inverso isomer of Angiopep-2: a stable d-peptide ligand inspires brain-targeted drug delivery.

  2014cites this paper
• Development and characterization of a co-culture two-dimensional blood-brain barrier for the study of nanoparticle permeation

  2014cites this paper
• Liposomes functionalized to overcome the blood–brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model

  2013cites this paper
• Prediction of passive blood-brain barrier permeability with PAMPA: from small molecules to complex formulations

  2013cites this paper
• The hCMEC/D3 cell line as a model of the human blood brain barrier

  2013cites this paper
• Multi-functionalized nanoparticles for therapy and diagnosis of alzheimer's disease

  2013cites this paper